MYGN – myriad genetics, inc. (US:NASDAQ)

News

Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026 [Yahoo! Finance]
Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026
Myriad Genetics (MYGN) was upgraded by TD Cowen to "hold".
Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan
GeneCentric to Present Data on Fragmentomics-Based ExpressCT™ Liquid Biopsy Technology at AACR 2026 [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com